Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Sept. 21, 2023 Chemoradiotherapy with concomitant nivolumab was found to be safe and effective for improving progression-free survival rates in cervical cancer. Concurrent chemoradiotherapy (CRT) improves immune-mediated tumor control by increasing phagocytosis and antigen presentation. The NiCOL phase I trial, conducted by Rodrigues et al., aimed to...